The active pharmaceutical ingredients market anticipated to surpass US$ 250.0 Bn mark by 2025. The growing ageing population, increasing access to better healthcare coupled financial and efficiency incentives attached with API outsourcing are driving the market and expected to boost the over the forecast years. Moreover, the outsourcing of Innovative and Generic APIs in recent times adding fuel for the market growth. However, the growing concerns about quality of final formulation and imposition of stringent regulations for product approvals  has led to the negative impact on the market and these may hinder the growth of API market over the forecast period.

 

Active pharmaceutical ingredients market has been researched based on API type, manufacturer type, synthesis type, application and region.

 

For request sample: https://www.precisionbusinessinsights.com/request-sample?product_id=15533

 

The Current Market for APIs is Driven By Captive Manufacturing

Based on manufacturer type, the active pharmaceutical ingredients market is segmented into captive API manufacturers and merchant API manufacturers. Among the manufacturers, captive API manufacturers holds the largest share and dominated the global active pharmaceutical ingredients market in 2018 and expected to grow at moderate CAGR over the forecast period since several innovative companies vertically integrated and developing in-house API manufacturing capabilities. However, merchant API manufacturers expected exhibit significant growth over the forecast period, this growth is mainly attributed to the growing restructuring of manufacturing activities of several large scale pharmaceutical companies, who are looking at cost-efficiency in the manufacturing operations.

                                                                                                                                      

North America Holds Large Chunk of Revenue in Global Active Pharmaceutical Ingredients (API) Market

Precision Business Insights (PBI), active pharmaceutical ingredients market report analyses the market in different regions such as North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. According to regional analysis, North America holds large revenue share and the market is expected to grow at significant CAGR over the forecast period owing to government decision to lower the healthcare expenditure, this has led to demand for generics and biosimilars across the healthcare value chain. Moreover, growing demand for complex and specialty biologics coupled growing incidence of several chronic disease driving the North America Active Pharmaceutical Ingredients (API) Market.

 

Long-term Manufacturing Agreements and Strategic Partnerships to Gain Sustainable Position in Active Pharmaceutical Ingredients (API) Market

In July 2019, Lonza and Omeros entered into long-term manufacturing agreement for commercial production of narsoplimab, Omeros’ lead human monoclonal antibody targeting mannan-binding lectin-associated serine protease-2 (MASP-2), also referred to as OMS721.

• In June 2017, BMS divested its small-molecule active pharmaceutical ingredient (API) production facility in Ireland, to South Korean firm SK BIOTEK CO. LTD.

 

Few player’s profiles in the report are Pfizer, Inc. (U.S.), Sanofi (France), Lonza Group (Switzerland), Boehringer Ingelheim (Germany), Novartis AG (Switzerland), GlaxoSmithKline plc (U.K.), Bristol-Myers Squibb (U.S.), Zhejiang Hisun Pharmaceutical Co., Ltd. (China), Aenova Group GmbH (Germany), Catalent, Inc. (U.S.), Teva Pharmaceutical Industries Ltd., (Israel) Aurobindo Pharma Limited (India), Eli Lilly and Company (U.S.), AbbVie Inc. (U.S.).,  and Merck & Co., Inc. (U.S.)

 

Precision Business Insights (PBI) in its report titled “Active Pharmaceutical Ingredients (API) Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2014-2018 and Forecast 2019-2025” assesses the market performance over seven years forecast period from 2019 to 2025. The report analyses the market value forecast and provides the strategic insights into the market driving factors, challenges that are hindering the market revenue growth over forecast period.

 

 

Detailed Segmentation

 

By APIs Type

• Innovative APIs
• Generic APIS

By Manufacturer Type

• Captive API Manufacturers
• Merchant API Manufacturers

• Merchant Innovative API Manufacturers
• Merchant Generic API Manufacturers
• Merchant API Manufacturers Market, by Type of Synthesis
• Merchant Synthetic API Manufacturers
• Merchant Biotech API Manufacturers

By  Synthesis Type

• Synthetic APIs Market

• Innovative Synthetic APIs
• Generic Synthetic APIs

• Biotech APIs Market

• Innovative Biotech APIs
• Generic Biotech APIs

• Biotech APIs Market, by Product

• Monoclonal Antibodies
• Hormones and Growth Factors
• Cytokines
• Fusion Proteins
• Therapeutic Enzymes
• Recombinant Vaccines
• Blood Factors

• Biotech APIs Market, by Expression System

• Mammalian Expression Systems
• Microbial Expression Systems
• Yeast Expression Systems
• Insect Expression Systems
• Other Expression Systems

By Therapeutic Application

• Communicable Diseases
• Oncology
• Diabetes
• Cardiovascular Diseases
• Pain Management
• Respiratory Diseases
• Other Therapeutic Applications

Geography

• North America

• U.S
• Canada

• Europe

• Germany
• France
• U.K
• Italy
• Spain
• Russia
• Poland
• Rest of Europe

• Asia-Pacific

• Japan
• China
• India
• Australia & New Zealand
• ASEAN (Includes Indonesia, Thailand, Vietnam, Philippines, Malaysia, and Others)
• South Korea
• Rest of Asia-Pacific

• Latin America

• Brazil
• Mexico
• Argentina
• Rest of Latin America

• Middle East and Africa (MEA)

• Gulf Cooperation Council (GCC) Countries
• Israel
• South Africa
• Rest of MEA

 

 

For more information: https://www.precisionbusinessinsights.com/market-reports/global-active-pharmaceutical-ingredient-api-market/

 

 

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customized market research services based on our client needs.

 

Kemp House,

152 – 160 City Road,

London EC1V 2NX

Email: sales@precisionbusinessinsights.com

Toll Free (US): +1-866-598-1553

Website @ https://www.precisionbusinessinsights.com